{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:02:03Z","timestamp":1771297323433,"version":"3.50.1"},"reference-count":38,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Lysi hf in Iceland"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The current paper reports the asymmetric synthesis of a focused library of enantiostructured triacylglycerols (TAGs) constituting a potent drug of the NSAID type (ibuprofen or naproxen) along with a pure bioactive n-3 polyunsaturated fatty acid (PUFA) intended as a novel type of prodrug. In this second category, a TAG prodrug of the terminal sn-1 or sn-3 position of the glycerol skeleton is acylated with a single saturated medium-chain fatty acid (C6, C8, C10, or C12), and another with the drug entity; the PUFA (EPA or DHA) is located in the sn-2 position. This was accomplished by a six-step chemoenzymatic approach, two of which were promoted by a lipase, starting from enantiopure (R)- and (S)-solketals. The highly regioselective immobilized Candida antarctica lipase (CAL-B) played a crucial role in the regiocontrol of the synthesis. The most challenging key step involved the incorporation of the drugs that were activated as oxime esters by the lipase exclusively in the terminal position of glycerol that is protected as a benzyl ether. All combinations, a total of 32 such prodrug TAGs, were prepared, isolated, and fully characterized, along with 24 acylglycerol intermediates, obtained in very-high-to-excellent yields in the majority of cases.<\/jats:p>","DOI":"10.3390\/molecules30050991","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:53:06Z","timestamp":1740124386000},"page":"991","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis of Enantiostructured Triacylglycerol Prodrugs Constituting an Active Drug Located at Terminal sn-1 and sn-3 Positions of the Glycerol Backbone"],"prefix":"10.3390","volume":"30","author":[{"given":"Lena R\u00f3s","family":"J\u00f3nsdottir","sequence":"first","affiliation":[{"name":"Science Institute, Chemistry Department, University of Iceland, Dunhaga 3, 107 Reykjavik, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5664-2745","authenticated-orcid":false,"given":"Gudmundur G.","family":"Haraldsson","sequence":"additional","affiliation":[{"name":"Science Institute, Chemistry Department, University of Iceland, Dunhaga 3, 107 Reykjavik, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"J\u00f3nsd\u00f3ttir, L.R., and Haraldsson, G.G. (2024). Synthesis of enantiostructured triacylglycerols possessing a saturated fatty acid, a polyunsaturated fatty acid and an active drug intended as novel prodrugs. Molecules, 29.","DOI":"10.20944\/preprints202410.1359.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ph2030077","article-title":"A new classification of prodrugs: Regulatory perspectives","volume":"2","author":"Wu","year":"2009","journal-title":"Pharmaceuticals"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: Design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Reviews. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrd.2018.46","article-title":"The expanding role of prodrugs in contemporary drug design and development","volume":"17","author":"Rautio","year":"2018","journal-title":"Nat. Reviews. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0928-0987(00)00161-5","article-title":"Rationale and application of lipids as prodrug carriers","volume":"11","author":"Lambert","year":"2000","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1208\/s12248-014-9670-z","article-title":"Lipid-based carriers for prodrugs to enhance delivery","volume":"17","author":"Zaro","year":"2015","journal-title":"AAPS J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3945\/ajcn.2009.28422","article-title":"Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity","volume":"91","author":"Chan","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_8","first-page":"1","article-title":"Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: Review of evidence and clinical relevance","volume":"381","author":"Savelieva","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhou, J., Lee, Y.-Y., Mao, Y., Wang, Y., and Zhang, Z. (2022). Future of structured lipids: Enzymatic synthesis and their new applications in food systems. Foods, 11.","DOI":"10.3390\/foods11162400"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1222373","DOI":"10.1155\/2023\/1222373","article-title":"An overview of structured lpids in food science: Synthesis, methods, applications and future prospects","volume":"2023","author":"Hong","year":"2023","journal-title":"J. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lopes, P.A., Alfaia, C.M., Pestana, J.M., and Prates, J.A.M. (2023). Structured lipids engineering for health: Novel formulations enriched in n-3 long-chain polyunsaturated fatty acids with potential nutritional benefits. Metabolites, 13.","DOI":"10.3390\/metabo13101060"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9101","DOI":"10.1016\/j.tet.2003.09.059","article-title":"Chemoenzymatic synthesis of structured triacylglycerols by highly regioselective acylation","volume":"59","author":"Halldorsson","year":"2003","journal-title":"Tetrahedron"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.tet.2010.01.110","article-title":"Chemoenzymatic synthesis of symmetrically structured triacylglycerols possessing short-chain fatty acids","volume":"66","author":"Magnusson","year":"2010","journal-title":"Tetrahedron"},{"key":"ref_14","unstructured":"Lembke, P. (2024). Omega-3 Fatty Acids: A Scientific Approach to Healthy Aging and Optimized Nutrition, Academic Press."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.clnu.2017.02.021","article-title":"Docosahexaenoic acid in the treatment of rheumatoid arthritis: A double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil","volume":"37","author":"Dawczynski","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Innes, J.K., and Calder, P.C. (2020). Marine omega-3 (n-3) fatty acids for cardiovascular health: An update for 2020. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041362"},{"key":"ref_17","unstructured":"Garcia-Moreno, P.J., Jacobsen, C., Moltke S\u00f6rensen, A.-D., and Yesiltas, B. (2021). Health benefits of omega-3 fatty acids. Omega-3 Delivery Systems: Production, Physical Characterization and Oxidative Stability, Elsevier."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2012","journal-title":"Chem. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: Novel macrophage mediators with potent antiinflammatory and proreseolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Novel pro-resolving lipid mediators in inflammation are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?","volume":"75","author":"Calder","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_22","first-page":"e673","article-title":"Omega-3 fatty acids for the management of hypertriglyceridemia: A science advisory from the American Heart Association","volume":"140","author":"Wilson","year":"2019","journal-title":"Circulation."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003495-200969080-00008","article-title":"Omega-3 ethylester concentrate: A review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia","volume":"69","author":"Hoy","year":"2009","journal-title":"Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jacl.2011.10.018","article-title":"Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review","volume":"6","author":"Jacobson","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jacl.2013.01.006","article-title":"Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized long-term (ORL) study","volume":"7","author":"Tatsuno","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacl.2013.09.002","article-title":"Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORL) study","volume":"7","author":"Tatsuno","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacl.2012.07.001","article-title":"Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)","volume":"6","author":"Bays","year":"2012","journal-title":"J. Clin. Lipidol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"130813","DOI":"10.1016\/j.tet.2019.130813","article-title":"Synthesis of Enantiopure ABC-Type Triacylglycerols","volume":"76","author":"Gudmundsson","year":"2020","journal-title":"Tetrahedron"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104937","DOI":"10.1016\/j.chemphyslip.2020.104937","article-title":"Synthesis and enantiospecific analysis of enantiostructured triacylglycerols containing n-3 polyunsaturated fatty acids","volume":"231","author":"Kalpio","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Haraldsdottir, H., Gudmundsson, H.G., Linderborg, K.M., Yang, B., and Haraldsson, G.G. (2024). Chemoenzymatic synthesis of ABC-type enantiostructured triacylglycerols by the use of the p-methoxybenzyl protective group. Molecules, 29.","DOI":"10.20944\/preprints202403.1034.v1"},{"key":"ref_31","unstructured":"Gunstone, F.D. (2004). The Chemistry of Oils and Fats: Sources, Composition, Properties and Uses, Blackwell Publishing."},{"key":"ref_32","unstructured":"(1977). IUPAC-IUB Commission on Biochemical Nomenclature, 1977. The nomenclature of lipids, Eur J. Biochem., 79, 11\u201321."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ghogare, A., and Kumar, G.S. (1989). Oxime esters as novel irreversible acyl transfer agents for lipase catalysis in organic media. J. Chem. Soc. Chem. Commun., 1533\u20131535.","DOI":"10.1039\/c39890001533"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/138527206777698093","article-title":"Stereoselective enzymatic acylations (transesterifications)","volume":"10","author":"Chenevert","year":"2006","journal-title":"Curr. Org. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Faber, K. (2004). 3.1.1 Ester synthesis. Biotransformations in Organic Chemistry, Springer.","DOI":"10.1007\/978-3-642-18537-3_1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chemphyslip.2012.07.005","article-title":"Activation of n-3 polyunsaturated fatty acids as oxime esters: A novel approach for their exclusive incorporation into the primary alcoholic positions of the glycerol moiety by lipase","volume":"165","author":"Magnusson","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"ref_37","unstructured":"Christie, W.W. (2003). Lipid Analysis: Isolation, Separation, Identification and Structural Analysis of Lipids, The Oily Press. [3rd ed.]. Chapter 4."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0009-3084(90)90111-4","article-title":"Acyl migration in 1,2-dipalmitoyl-sn-glycerol","volume":"52","author":"Kodali","year":"1990","journal-title":"Chem. Phys. Lipids"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/5\/991\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:39:35Z","timestamp":1760027975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/5\/991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["molecules30050991"],"URL":"https:\/\/doi.org\/10.3390\/molecules30050991","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}